ArticleEuropean journal of clinical pharmacology2016

Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006-2015: a cohort study.

Denis Boucaud-Maitre et al.PubMed ↗Publisher ↗

No numbers read from the abstract.